Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Grohmann

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1996
IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cellsR Bianchi, U Grohmann, M L Belladonna, et al.
Critical Reviews in Immunology|January 7, 1998
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptideU Grohmann, M C Fioretti, R Bianchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gammaU Grohmann, M L Belladonna, Carmine Vacca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivoU Grohmann, R Bianchi, M L Belladonna, et al.
European Journal of Immunology|June 1, 1994
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivityP Puccetti, R Bianchi, M C Fioretti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cellsU Grohmann, F Fallarino, S Silla, et al.
European Journal of Immunology|October 1, 1995
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptideU Grohmann, R Bianchi, M C Fioretti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenaseU Grohmann, F Fallarino, R Bianchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2001
IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10U Grohmann, J Van Snick, F Campanile, et al.
International Journal of Cancer|September 30, 1992
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal levelU Grohmann, P Puccetti, L Romani, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1996
IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cellsR Bianchi, U Grohmann, M L Belladonna, et al.
Critical Reviews in Immunology|January 7, 1998
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptideU Grohmann, M C Fioretti, R Bianchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gammaU Grohmann, M L Belladonna, Carmine Vacca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivoU Grohmann, R Bianchi, M L Belladonna, et al.
European Journal of Immunology|June 1, 1994
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivityP Puccetti, R Bianchi, M C Fioretti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cellsU Grohmann, F Fallarino, S Silla, et al.
European Journal of Immunology|October 1, 1995
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptideU Grohmann, R Bianchi, M C Fioretti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenaseU Grohmann, F Fallarino, R Bianchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2001
IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10U Grohmann, J Van Snick, F Campanile, et al.
International Journal of Cancer|September 30, 1992
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal levelU Grohmann, P Puccetti, L Romani, et al.
Pageof 6